This CJC-1295 (No DAC) and Ipamorelin blend pairs a GHRH analog with a selective ghrelin receptor agonist, one of the most studied dual-pathway combinations in growth hormone axis research.
This combination research peptide joins CJC-1295 without DAC (also known as Mod GRF 1-29), a GHRH analog with a shorter, more pulsatile activity profile, with Ipamorelin, a selective GHS-R agonist. The pairing stimulates the growth hormone axis through two complementary receptor pathways and is among the most frequently referenced combinations in secretagogue research literature.
Research Applications
Handling & Storage
Supplied as a lyophilized powder. Store sealed vials in a cool, dry place away from light; refrigerate after reconstitution with bacteriostatic water and avoid repeated freeze-thaw cycles.
This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
This CJC-1295 (No DAC) and Ipamorelin blend pairs a GHRH analog with a selective ghrelin receptor agonist, one of the most studied dual-pathway combinations in growth hormone axis research. This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 4PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
Every batch of CJC-1295/Ipamorelin(No DAC) is independently tested for identity and purity, and ships with its own Certificate of Analysis — lot information included, where a researcher can actually find it.
View Testing Documentation →Batch COA provided with every order.
